Background: Prophylactic mesh-augmented reinforcement during closure of abdominal wall incisions has been proposed in patients with increased risk for development of incisional hernias (IHs). As part of the BioMesh consensus project, a systematic literature review has been performed to detect those studies where MAR was performed with a non-permanent absorbable mesh (biological or biosynthetic).
iNTRODUCTiON Prophylactic mesh-augmented reinforcement during closure of abdominal wall incisions has been proposed in patients at high risk for incisional hernia (IH). Several randomized clinical trials (RCTs) have been published on the use of prophylactic mesh in patients undergoing aortic aneurysm surgery (1) (2) (3) (4) , obesity surgery (3, (5) (6) (7) , stoma creation (8) (9) (10) (11) (12) (13) (14) , in colorectal cancer patients (15, 16) , or other high-risk patients (17, 18) . The recently published guidelines of the European Hernia Society have provided the following weak recommendation: "Prophylactic mesh augmentation for an elective midline laparotomy in high-risk patients in order to reduce the risk of incisional hernias is suggested. " Due to the lack of sufficient data, no recommendations on the type of mesh, the optimal mesh position, or the optimal mesh fixation technique could be made (19) . Although prophylactic mesh-augmented reinforcement has been performed safely in clean-contaminated setting, one concern is the potential short-or long-term harms by implantation of a permanent mesh (20) . Application of a non-permanent absorbable for prophylactic mesh-augmented reinforcement might therefore hold some benefit if these meshes will be as effective as permanent meshes. A systematic literature review has been performed to detect those studies where prophylactic mesh-augmented reinforcement was performed with a non-permanent absorbable biological or biosynthetic mesh and provide guidance for future research on the use of biological or biosynthetic meshes.
MeTHODS

Protocol
The systematic search was part of the BioMesh consensus project. This project, initiated by Ferdinand Köckerling, gathered surgical expertise in a working group to provide a summary on the use of non-permanent absorbable biological or biosynthetic meshes in different indications. During a consensus meeting in Berlin on January 27, 2016, the working group decided in consensus on the statements and conclusions derived from the level of evidence for each indication. This manuscript reports on the review of the use of non-permanent absorbable biological or biosynthetic meshes for the prevention of IHs.
eligibility Criteria
Inclusion criteria: because of the paucity of available studies on prophylactic mesh-augmented reinforcement with biological or biosynthetic mesh for the prevention of IHs, no limitation, to the study design, length of follow-up, or number of included patients, was used.
Exclusion criteria: prevention of parastomal hernias were excluded because this was part of a separate search within the BioMesh study group (21) .
information Sources
A computerized search was performed within 12 databases (Embase, Medline, Web-of-Science, Scopus, Cochrane, CINAHL, Pubmed publisher, Lilacs, Scielo, ScienceDirect, ProQuest, Google Scholar) on June 25, 2015.
Search
The biomedical librarian of the Erasmus University Medical Centre, Rotterdam, The Netherlands performed the search, and the search strategy is provided in Section "Addendum 1" in Appendix.
Study Selection
From the search, only the studies reporting on the use of a nonpermanent absorbable biological or biosynthetic mesh were retained. Studies written in English, Dutch, French, and Spanish were considered.
Data Collection Process
Two authors (Filip Etienne Muysoms and An Jairam) independently screened all records retrieved upon application of the search strategy by title and abstract. The full text of all retained records was screened for eligibility. The references of all review articles found were cross-checked for additional eligible records.
Data items
The following data were extracted by two authors independently and cross-checked: type of study, number of patients included, patient characteristics, indication for surgery, type of biological mesh, position of the mesh, method of mesh fixation, length of follow-up, and outcome measures (hernias, seroma, wound infections, burst abdomen). Primary outcome was IH incidence, and secondary outcomes were postoperative seroma, wound infection, and burst abdomen.
Quality Assessment of individual Studies
Qualitative evaluation was performed using the MINORS score for non-randomized studies (22) and the Jadad score for RCTs (23) . Additionally, the quality of evidence across the RCTs was done using the GRADE Pro software. 1 
Statistical Analysis
A meta-analysis of the outcome from the RCTs detected was performed for relevant outcomes: IH, seroma, wound infections, and burst abdomen. Meta-analysis was performed using the Review Manager 5.3 software (Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2013). Our outcomes were expressed as risk ratios (RRs) with 95% confidence intervals (CIs) to estimate the pooled effect size and p-value. All tests were two-sided.
ReSULTS
Study Selection
The PRISMA flow diagram of our search is illustrated in Figure 1 . Six studies were retained after the screening and sift for eligibility. Four studies included patients with midline laparotomy (2, 7, 24, 25) , and two studies investigated the prevention of IHs after stoma reversal (26, 27) . 
Study Characteristics
Midline Laparotomy
Our literature review revealed four studies where a biological mesh was used to prevent IHs in high-risk patients. Details of the study characteristics and quality assessment (MINORS score, Jadad score) are shown in the summary of evidence table ( Table 1) . A small cohort study on eight patients that underwent a midline laparotomy for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) described short-term outcome using an intraperitoneal biological mesh (24) . In a prospective non-randomized case-control study, obese patients operated for a gastric bypass through a midline laparotomy were either treated with an intraperitoneal biological mesh (n = 59) or primary suture closure (n = 75). A significant reduction in the number of IHs by prophylactic mesh was reported [2.3% (90% CI: 2.31-6.86) versus 17.7% (90% CI: 7.92-27.52), p = 0.014] (25) . In an RCT in obese patients undergoing a gastric bypass operation through a midline laparotomy, patients were randomized between an intraperitoneal biological mesh (n = 185) and primary suture closure (n = 195). This adequately powered RCT, did not show any benefit for prophylactic mesh concerning the risk for IH at 24 months (17.3 versus 19.5%, p = 0.60), but did show a significant higher number of wound infections and wound seroma in the mesh group (7) . In an RCT of aortic aneurysm patients, midline laparotomy closure with an onlay biologic mesh (n = 20) was compared to primary suture closure (n = 20) (2). The study was not powered with a sample size calculation, but the follow up was adequate in length (36 months) and methodology (systematic CT 
Stoma Reversal Wound
Our literature review revealed two studies in which a biological mesh was used to prevent IHs after reversal of a temporary ileostomy. Details of the studies are shown in the summary of evidence table ( Table 2 ). In a pilot study with a limited patient population (n = 7), the feasibility of an intraperitoneal prophylactic mesh was investigated in terms of safety in the short term (27) . The second report was a matched case-control study of 30 patients that received a retro-muscular prophylactic biological mesh, compared to 64 matched patients with suture closure of the stoma wound. At 1-year follow-up with CT scan, the number of patients with IH was significantly lower for the mesh group (p = 0.043).
Meta-analysis
The pooled analysis for the outcome IH showed no statistical differences between groups (RR 0.38, 95% CI 0.04-3.83; p = 0.41). The forest plots of the meta-analysis of the two RCTs on prevention of midline laparotomy IHs, and the secondary outcomes are shown in Figure 2 .
DiSCUSSiON Midline Laparotomy
Overall, the Level of Evidence on the efficacy of biological mesh to prevent IHs is very low. Moreover, the study with the highest level of evidence and lowest risk of bias did not show any advantage in reducing IHs by prophylactic intraperitoneal biological mesh in patients undergoing a midline laparotomy for performing gastric bypass surgery (7). On the contrary, it did show a higher number of wound complications after the use of the prophylactic mesh. Another study regarding gastric bypass patients did show a benefit, but this study was non-randomized and had a high risk of bias (25) . For aortic aneurysm patients, only one RCT is available, which showed a high efficacy with 3 years follow-up. However, this study was poorly powered, non-blinded, and scored low in the Jadad scale (2). Moreover, no information on sources of funding and protocol registration was provided, and therefore, the risk of bias cannot be assessed.
The currently available evidence is not strong enough to make any statements regarding the optimal mesh position (intraperitoneal, retro-muscular, or onlay) in case a prophylactic biological mesh is used. Also, the different meshes used in the studies (non-cross-linked human origin; non-cross-linked porcine small intestinal submucosa; cross-linked bovine pericardium) might have an important impact on the outcome.
On the contrary, the Level of Evidence on the efficacy of prophylactic synthetic non-absorbable mesh (all polypropylene) in high-risk patients currently is high, with 8 published RCTs encompassing 727 patients with a follow-up of at least 12 months (1, 4-6, 15-18) . Moreover, the safety of prophylactic retro-muscular or onlay meshes in clean or clean-contaminated surgery is shown in 9 published RCTs encompassing 1207 patients (1, (3) (4) (5) (6) (15) (16) (17) (18) .
No comparative studies were found comparing biological mesh with synthetic non-absorbable meshes for the prevention of IHs. There is a study ongoing at the Vall d'Hebron Hospital, Universidad Autónoma de Barcelona on the prevention of IHs from midline laparotomies using an absorbable synthetic mesh (Bio-A, WL Gore & Ass, USA), PREBIOUS trial. 
Stoma Reversal wound
Overall, the Level of Evidence on the efficacy of biological mesh to prevent IHs of stoma reversal wounds is very low. Currently, the only study providing evidence is a matched case-control study, showing a lower IH rate at 1 year. This study is a pilot study for an RCT that is planned in France, the MEMBO trial 3 (27) . The small pilot study by Banghu et al. is part of a large project, the ROCSS study, which is a properly powered multicenter RCT from the University of Birmingham 4 (26) . This study compares the technique described in the pilot study with sutured closure of the stoma wound and has now included 790 patients, and the followup is ongoing. Furthermore, a study from the Vall d'Hebron Hospital (Universidad Autónoma de Barcelona), ILEOCLOSE study, 5 will investigate in a RCT the application of prophylactic mesh reinforcement of closure of temporary diverting ileostomy with an absorbable synthetic mesh (Bio-A) in 120 patients.
CONCLUSiON
So far, there is no solid evidence on the effectiveness of prophylactic non-permanent absorbable biological or biosynthetic mesh for the closure of midline laparotomies or reinforcement of a stoma reversal site. There is no evidence that, in this setting, a non-permanent absorbable biological or biosynthetic mesh should be preferred to synthetic non-absorbable mesh, both in clean or clean-contaminated surgery.
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